Taken all together, we provide compelling evidence that EGF–ERK1/2 signaling pathways are responsible for upregulating the formation of large-sized glucosomes in cancer cells, thus promoting glucose flux into serine biosynthesis for cancer cell metabolism. This evidence concerns the gene EGF and cancer.